Off-Package Labeling For Small Cosmetic-Drugs Suggested By CTFA
This article was originally published in The Tan Sheet
Executive Summary
Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry & Fragrance Association suggested during an agency-industry workshop in Rockville, Md. Sept. 17.
You may also be interested in...
Block Drug Small Package Labeling Exemption Denial Mishandled - CHPA
FDA erred in denying Block Drug's request for an exemption from the OTC labeling final rule, the Consumer Healthcare Products Association says in an Oct. 3 letter to the agency.
CHPA Requests Two-Year Extension For OTC Labeling Final Rule
A two-year extension of the implementation deadlines for FDA's final rule on over-the-counter drug labeling is requested by the Consumer Healthcare Products Association in a citizen petition submitted to the agency Oct. 1.
Trade Dress Changes May Interfere With Intellectual Property Protection
A change in a product's trade dress as a result of the OTC labeling final rule requirements would violate intellectual property protection by restricting product distinctiveness, attorney Charles Buffon, Covington & Burling, asserted at an FDA working group on the OTC labeling reg in Rockville, Md. Aug. 24.